Related references
Note: Only part of the references are listed.Recent progress towards development of a Shigella vaccine
Ana Isabel Camacho et al.
EXPERT REVIEW OF VACCINES (2013)
Progress and pitfalls in Shigella vaccine research
Eileen M. Barry et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Studies of the conformational stability of invasion plasmid antigen B from Shigella
Shyamal P. Choudhari et al.
PROTEIN SCIENCE (2013)
Oligomeric states of the Shigella translocator protein IpaB provide structural insights into formation of the type III secretion translocon
Nicholas E. Dickenson et al.
PROTEIN SCIENCE (2013)
Parenteral immunization with IpaB/IpaD protects mice against lethal pulmonary infection by Shigella
Francisco J. Martinez-Becerra et al.
VACCINE (2013)
Evaluation of immunogenicity and protective efficacy of orally delivered Shigella type III secretion system proteins IpaB and IpaD
Shannon J. Heine et al.
VACCINE (2013)
Broadly Protective Shigella Vaccine Based on Type III Secretion Apparatus Proteins
Francisco J. Martinez-Becerra et al.
INFECTION AND IMMUNITY (2012)
The A Subunit of Escherichia coli Heat-Labile Enterotoxin Functions as a Mucosal Adjuvant and Promotes IgG2a, IgA, and Th17 Responses to Vaccine Antigens
Elizabeth B. Norton et al.
INFECTION AND IMMUNITY (2012)
Comparison of the prevalence and changing resistance to nalidixic acid and ciprofloxacin of Shigella between Europe-America and Asia-Africa from 1998 to 2009
Bing Gu et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Diarrhea Outbreak during US Military Training in El Salvador
Matthew R. Kasper et al.
PLOS ONE (2012)
Immunogenicity of a Fusion Protein Containing Immunodominant Epitopes of Ag85C, MPT51, and HspX from Mycobacterium tuberculosis in Mice and Active TB Infection
Eduardo Martins de Sousa et al.
PLOS ONE (2012)
Two live attenuated Shigella flexneri 2a strains WRSf2G12 and WRSf2G15: A new combination of gene deletions for 2nd generation live attenuated vaccine candidates
Ryan T. Ranallo et al.
VACCINE (2012)
Outer Membrane Protein A (OmpA) of Shigella flexneri 2a, Induces Protective Immune Response in a Mouse Model
Debasis Pore et al.
PLOS ONE (2011)
Safety and immunogenicity of an intranasal Shigella flexneri 2a Invaplex 50 vaccine
Mark S. Riddle et al.
VACCINE (2011)
Therapeutic efficacy of oral immunization with attenuated Salmonella typhimurium expressing Helicobacter pylori CagA, VacA and UreB fusion proteins in mice model
Kai-Yun Liu et al.
VACCINE (2011)
Emergence of a New Multidrug-Resistant Serotype X Variant in an Epidemic Clone of Shigella flexneri
Changyun Ye et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Th17 Cells Are the Dominant T Cell Subtype Primed by Shigella flexneri Mediating Protective Immunity
Gernot Sellge et al.
JOURNAL OF IMMUNOLOGY (2010)
A Look Back at an Ongoing Problem: Shigella dysenteriae Type 1 Epidemics in Refugee Settings in Central Africa (1993-1995)
Solen Kerneis et al.
PLOS ONE (2009)
Deoxycholate interacts with IpaD of Shigella flexneri in inducing the recruitment of IpaB to the type III secretion apparatus needle tip
Kenneth F. Stensrud et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Preparation and characterization of translocator/chaperone complexes and their component proteins from Shigella flexneri
Susan E. Birket et al.
BIOCHEMISTRY (2007)
Immunogenicity and protective efficacy offered by a ribosomal-based vaccine from Shigella flexneri 2a
Doo-Hee Shim et al.
VACCINE (2007)
IpaD localizes to the tip of the type III secretion system needle of Shigella flexneri
Marianela Espina et al.
INFECTION AND IMMUNITY (2006)
Roles for T and NK cells in the innate immune response to Shigella flexneri
K Le-Barillec et al.
JOURNAL OF IMMUNOLOGY (2005)
Protein production by auto-induction in high-density shaking cultures
FW Studier
PROTEIN EXPRESSION AND PURIFICATION (2005)
Predominance of serotype-specific mucosal antibody response in Shigella flexneri-infected humans living in an area of endemicity
V Rasolofo-Razanamparany et al.
INFECTION AND IMMUNITY (2001)
Share Paper
